The effects of treatment with interleukin-1 alpha on platelet recovery after high-dose carboplatin.

Smith, J W; Longo, D L; Alvord, W G; Janik, J E; Sharfman, W H; Gause, B L; Curti, B D; Creekmore, S P; Holmlund, J T; Fenton, R G

Smith, J W; Longo, D L; Alvord, W G; Janik, J E; Sharfman, W H; Gause, B L; Curti, B D; Creekmore, S P; Holmlund, J T; Fenton, R G.

Affiliation

Smith JW; Biological Response Modifiers Program, Frederick Cancer Research and Development Center, National Cancer Institute, Md.

N Engl J Med ; 328(11): 756-61, 1993 Mar 18.

Article in En | MEDLINE | ID: mdl-8437596

Subject(s)

Carboplatin/adverse effects; Interleukin-1/therapeutic use; Thrombocytopenia/therapy; Adult; Aged; Carboplatin/administration & dosage; Drug Therapy, Combination; Female; Humans; Interleukin-1/administration & dosage; Male; Middle Aged; Neoplasms/drug therapy; Pilot Projects; Platelet Count; Thrombocytopenia/chemically induced; Time Factors

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Thrombocytopenia / Carboplatin / Interleukin-1 Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: N Engl J Med Year: 1993 Type: Article Affiliation country: Moldova

Search on Google

XML

PubMed Links